6 Results for "

exponential phase

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "exponential phase" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-Y1718
CAS No.: 638-53-9
Synonyms: N-Tridecanoic acid
Tridecanoic acid (N-Tridecanoic acid) is a medium-chain saturated fatty acid and inhibitor with no antibacterial activity against enterohemorrhagic E. coli (EHEC). When used in combination with Ciprofloxacin (HY-B0356) or Ampicillin (HY-B0522), Tridecanoic acid suppresses persister formation in exponentially growing E. coli and EHEC, but exerts no inhibitory effect on persister formation induced by Kanamycin (HY-16566) or in stationary-phase cells. Tridecanoic acid inhibits biofilm formation in EHEC. It can be used in the research of bacterial infections .
loading...
    loading...
Cat. No.: HY-W001968
CAS No.: 498-62-4
Synonyms: 3-TC
Target:  

Drug Intermediate

Research Areas:  

Others

3-Thiophenecarboxaldehyde is a thiophene derivative substrate for biocatalytic reduction to 3-thiophenemethanol, and can be processed by Pseudomonas putida S12 cells. 3-Thiophenecarboxaldehyde functions as an intermediate compound. 3-Thiophenecarboxaldehyde exhibits toxicity toward Pseudomonas putida S12 cells at elevated concentrations, reducing specific growth rate and final biomass yield .
loading...
    loading...
Cat. No.: HY-144326
CAS No.: 2766509-32-2
Target:  

Amyloid-β

Research Areas:  

Neurological Disease

Aβ-IN-1 is a Aβ1-42 aggregation inhibitor. Aβ-IN-1 inhibits Aβ1-42 self-aggregation in vitro by delaying the exponential growth phase or reduces the quantity of fibrils in the steady state. Aβ-IN-1 can be used for the research of conformational disorders .
loading...
    loading...
Cat. No.: HY-144327
Target:  

Amyloid-β

Research Areas:  

Neurological Disease

Aβ-IN-2 is a Aβ1-42 aggregation inhibitor. Aβ-IN-2 inhibits Aβ1-42 self-aggregation in vitro by delaying the exponential growth phase or reduces the quantity of fibrils in the steady state. Aβ-IN-2 can be used for the research of conformational disorders .
loading...
    loading...
Cat. No.: HY-N16428
CAS No.: 2152-59-2
Synonyms: NSC 356436
Neoaspergillic acid (NSC 356436) (Compound 2) is a microbial secondary metabolite. Neoaspergillic acid can be isolated from the endophytic fungus Aspergillus sp. SPH2. Neoaspergillic acid has potent antifungal activity against Alternaria alternata, Botrytis cinerea and Fusarium oxysporum. Neoaspergillic acid appears during the exponential phase of fungal growth. Neoaspergillic acid also antitumor and antibacterial effects .
loading...
    loading...
Cat. No.: HY-183480
CAS No.: 80841-47-0
Synonyms: CI-921; NSC 343499
Target:  

Topoisomerase

Research Areas:  

Cancer

Asulacrine (CI-921) is an orally active DNA intercalating topoisomerase II inhibitor. Asulacrine binds to DNA via intercalation, with its acridine chromophore intercalated between base pairs and substituents located in the major/minor grooves, which stabilizes DNA against acid denaturation. Asulacrine acts as a cell cycle inhibitor, disruptor, and arrest inducer, slowing cell progression in late S/G2 phase, causing G2 phase arrest and inducing unbalanced growth. Asulacrine inhibits cell growth, clonogenicity, and colony formation, and leads to histological destruction of tumor cells. Compared to cells in exponential growth phase, Asulacrine exhibits lower toxicity to quiescent cells; its activity depends on cationic properties, and it has better water solubility and metabolic stability. Asulacrine can be used in research related to leukemia, lung cancer, colon cancer, breast cancer, melanoma, adriamycin-resistant mammary adenocarcinoma, and mouse solid tumors .
loading...
    loading...